Table1 Analysis results of quality control data
Group | Raw PE | Combined | Qualified | Q20 | Q30 | GC% | Effective% |
|---|---|---|---|---|---|---|---|
Control | 100,108.33 | 95,507.5 | 93,342.17 | 98.61 | 95.20 | 53.36 | 62.71 |
Qi-yin deficiency | 104,656.67 | 100,071.67 | 97,838.5 | 98.64 | 95.36 | 53.73 | 63.87 |
LPS-ATP | 103,748.33 | 101,423.83 | 99,261.17 | 98.59 | 95.20 | 53.34 | 63.26 |
Qi-yin deficiency + LPS-ATP | 100,491.83 | 95,192.83 | 92,864.67 | 98.62 | 95.29 | 53.33 | 63.08 |
Positive group | 102,530.17 | 100,044.83 | 98,036.50 | 98.62 | 95.27 | 53.44 | 62.91 |
Low-dose group | 97,241.00 | 93,735.67 | 91,549.00 | 98.62 | 95.30 | 53.20 | 65.62 |
Middle-dose group | 104,181.67 | 102,379.17 | 100,339.83 | 98.62 | 95.31 | 53.78 | 63.20 |
High-dose group | 102,663.67 | 98,177.00 | 95,822.00 | 98.45 | 94.82 | 52.76 | 66.01 |